Mitxelena, A., and M. Areses. “Bezlotoxumab Can Reduce the Risk of Clostridium Difficile Recurrence”. Osagaiz: Osasun-Zientzien Aldizkaria, vol. 6, no. 1, July 2022, https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/362.